Log In
Thursday 18th July 2019

Global action needed to tackle hepatitis

28th July 2011

Medical experts writing in The Lancet have called for global action to tackle the viruses that cause the liver disease hepatitis.

The first worldwide estimates in drug users show 10 million have hepatitis C while 1.3 million have hepatitis B but there are concerns that only a fraction of those who could benefit are receiving antiviral drugs. Only one in five infants around the world are vaccinated against hepatitis B at birth, while 67% of injecting drug users in the world have been exposed to hepatitis C and 10% have come into contact with hepatitis B.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019